The New Humphrey Field Analyzer 3 from ZEISS

Article

The New HFA3 offers gold-standard perimetry performance with technological advances – such as automated trial lens correction with liquid lens technology – that are designed to save time and reduce errors.

The New Humphrey Field Analyzer 3 from ZEISS

Setting a New Standard for Efficient Visual Field Testing


The new Humphrey Field Analyzer 3 (HFA3) from ZEISS, is the next generation in visual field testing and analysis. The HFA3 is designed to accelerate clinic flow while delivering the same gold-standard testing strategies and test patterns.

The New HFA3 provides a streamlined and faster workflow with an array of new features designed to:

  • Reduce setup time with a single trial lens. Using liquid pressure, the new Liquid Trial Lens™ instantly delivers each patient’s refractive correction with the touch of a button.*

  • Save time with an intuitive new SmartTouch™ interface, which reduces the number of steps required for the technician to start a perimetry exam.

  • Accelerate clinic flow with equipment that can be learned quickly and operated easily.

  • Improve confidence in test results with RelEYE™, which allows doctors to instantly review the patient’s eye position, at any stimulus point. RelEYE data is available on the instrument and when reviewing test results with FORUM® Glaucoma Workplace.

  • Simplify test administration, with an easy-to-use kinetic graphical user interface with a full 180-degree field of view.

 

Find out more: www.zeiss.com/HFA3Contact us: www.meditec.zeiss.com/contacts

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.